Dopamine infusion and anterior pituitary gland function in very low birth weight infants

Biology of the Neonate

Volumn 89, Issue 4, 2006, Pages 274-280

  Filippi, Luca ^a   Pezzati, Marco ^a   Cecchi, Alessandra ^a   Serafini, Lisa ^a   Poggi, Chiara ^a   Dani, Carlo ^a   Tronchin, Michele ^a   Seminara, Salvatore ^b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Dopamine; Endocrinology; Growth hormone; Pituitary; Preterm newborn; Prolactin; Thyroid; Thyroid stimulating hormone

Indexed keywords

BETAMETHASONE; DOPAMINE; GROWTH HORMONE; PLASMA SUBSTITUTE; PROLACTIN; STEROID; THYROTROPIN; THYROXINE;

ADENOHYPOPHYSIS; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOPHYSIS FUNCTION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; OBSERVATIONAL STUDY; POSTPRANDIAL STATE; PREMATURITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL; VERY LOW BIRTH WEIGHT;

DOPAMINE; FEMALE; GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; PITUITARY GLAND, ANTERIOR; PROLACTIN; THYROTROPIN; THYROXINE; TIME FACTORS;

EID: 33745106840     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091741     Document Type: Article

References (28)

1. Seri I: Cardiovascular, renal and endocrine actions of dopamine in neonates and children. J Pediatr 1995;126:333-344.
2. Leebaw WF, Lee LA, Woolf PD: Dopamine affects basal and augmented pituitary hormone secretion. J Clin Endocrinol Metab 1978;47:480-487.
3. Samuels MH, Henry P, Ridgway EC: Effects of dopamine and somatostatin on pulsatile pituitary glycoprotein secretion. J Clin Endocrinol Metab 1992;74:217-222.
4. Seri I, Tulassay T, Kiszel J, Sulyok E, Ertl T, Bodis J, Csomor S: Effect of low-dose dopamine therapy on catecholamine values in cerebrospinal fluid in preterm neonates. J Pediatr 1984;105:489-491.
5. Wood DF, Johnston JM, Johnston DG: Dopamine, the dopamine D2 receptor and pituitary tumours. Clin Endocrinol 1991;35:455-466.
6. Filippi L, Cecchi A, Tronchin M, Dani C, Pezzati M, Seminara S, Gasperini S, Zammarchi E, Rubaltelli FF: Dopamine infusion and hypotiroxinemia in very low birth weight preterm infants. Eur J Pediatr 2004;163:7-13.
7. Järnberg PO, Bengtsson L, Ekstrand J, Hamberger B: Dopamine infusion in man: plasma catecholamine levels and pharmacokinetics. Acta Anaesthesiol Scand 1981;25:328-331.
8. Van den Berghe G, de Zegher F, Lauwers P: Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol 1994;41:731-737.
9. Ben-Jonathan N: Dopamine: a prolactin-inhibiting hormone. Endocr Rev 1985;6:564-589.
10. Cunnah D, Besser M: Management of prolactinomas. Clin Endocrinol 1991;34:231-235.
11. Van den Berghe G, de Zegher F, Lauwers P, Veldhuis JD: Growth hormone secretion in critical illness: effect of dopamine. J Clin Endocrinol Metab 1994;79:1141-1146.
12. Fisher DA, Dussalt JH, Sack J, Chopra IJ: Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep, and rat. Recent Prog Horm Res 1977;33:59-116.
13. Seri I, Tulassay T, Kiszel J, Ruppert F, Sulyok E, Ertl T, Bodis J, Csomor S: Effect of low-dose dopamine infusion on prolactin and thyrotropin secretion in preterm infants with hyaline membrane disease. Biol Neonate 1985;47:317-322.
14. Van den Berghe G, de Zegher F, Lauwers P: Dopamine suppresses pituitary function in infants and children. Crit Care Med 1994;22:1747-1753.
15. de Zegher F, Devlieger H, Veldhuis JD: Properties of growth hormone and prolactin hypersecretion by the human infant on the day of birth. J Clin Endocrinol Metab 1993;76:1177-1181.
16. Perlman M, Schenker J, Glassman M, Ben-david M: Prolonged hyperprolactinemia in preterm infants. J Clin Endocrinol Metab 1978;47:894-897.
17. de Zegher F, Van den Berghe G, Devlieger H, Eggermont E, Veldhuis JD: Dopamine inhibits growth hormone and prolactin secretion in the human newborn. Pediatr Res 1993;34:642-645.
18. Seri I, Somogyvari Z, Hovanyovszky S, Kiszel J, Tulassay T: Developmental regulation of the inhibitory effect of dopamine on prolactin release in the preterm neonate. Biol Neonate 1998;73:137-144.
19. Frank JE, Faix JE, Hermos RJ, Mullaney DM, Rojan DA, Mitchell ML, Klein RZ: Thyroid function in very low birth weight infants: effects on neonatal hypothyroidism screening. J Pediatr 1996;128:548-554.
20. Varvarigou A, Vagenakis AG, Makri M, Frimas C, Beratis NG: Prolactin and growth hormone in perinatal asphyxia. Biol Neonate 1996;69:76-83.
21. Biswas S, Buffery J, Enoch H, Bland JM, Walters D, Markiewicz M: A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome. Pediatrics 2002;109:222-227.
22. Ogilvy-Stuart AL, Hands SJ, Adcock CJ, Holly JM, Matthews DR, Mohamed-Ali V, Yudkin JS, Wilkinson AR, Dunger DB: Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. J Clin Endocrinol Metab 1998;83:3550-3557.
23. Redding RA, Douglas WHJ, Stein M: Thyroid hormone influence upon lung surfactant metabolism. Science 1972;175:994-996.
24. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, Kuban K, Van Marter LJ, Pagano M: Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr 1999;134:706-711.
25. Lucas A, Baker BA, Cole TJ: Plasma prolactin and clinical outcome in preterm infants. Arch Dis Child 1990;65:977-983.
26. Wilmore DW: Catabolic illness: strategies for enhancing recovery. New Engl J Med 1991;325:695-702.
27. Briet JM, van Wassenaer AG, Dekker FW, de Vijlder JJM, van Baar A, Kok JH: Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001;107:712-718.
28. Van Wassenaer AG, Kok JH, de Vijlder JJM, Briet JM, Smit BJ, Tamminga P, van Baar AL, Dekker FW, Vulsma T: Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. New Engl J Med 1997;336:21-26.